Evidence map›Paper›PMID 30250269›Full record

ArticleCell death & disease2018

MARVELD1 depletion leads to dysfunction of motor and cognition via regulating glia-dependent neuronal migration during brain development.

Weizhe Liu, Fang Han, Shuai Qu, Yuanfei Yao, Jianxiang Zhao, Muhammad Luqman Akhtar, Yanpeng Ci, Hao Zhang, Hongfei Li, Yufang Zhao and 4 more

Open access · goldAbstract read
In one paragraph

Article in Cell death & disease, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.3field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Up-regulation of MARVEL domain-containing protein 1 (MARVELD1) accelerated the malignant phenotype of glioma cancer cells via mediating JAK/STAT signaling pathway.Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologica · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 1 country.

Weizhe LiuSchool of Life Science and Technology, Harbin Institute of Technology, 150000, Harbin, China.
Fang HanSchool of Life Science and Technology, Harbin Institute of Technology, 150000, Harbin, China.
Shuai QuSchool of Life Science and Technology, Harbin Institute of Technology, 150000, Harbin, China.
Yuanfei YaoDepartment of Gastrointestinal Medical Oncology, Harbin Medical University Cancer Hospital, 150081, Harbin, China.
Jianxiang ZhaoSchool of Life Science and Technology, Harbin Institute of Technology, 150000, Harbin, China.
Muhammad Luqman AkhtarSchool of Life Science and Technology, Harbin Institute of Technology, 150000, Harbin, China.
Yanpeng CiSchool of Life Science and Technology, Harbin Institute of Technology, 150000, Harbin, China.
Hao ZhangFirst college of clinical medicine, Nanjing university of Chinese medicine, 210000, Nanjing, China.
Hongfei LiSchool of Life Science and Technology, Harbin Institute of Technology, 150000, Harbin, China.
Yufang ZhaoSchool of Life Science and Technology, Harbin Institute of Technology, 150000, Harbin, China.
Lei YueSchool of Life Science and Technology, Harbin Institute of Technology, 150000, Harbin, China.
Yao ZhangSchool of Life Science and Technology, Harbin Institute of Technology, 150000, Harbin, China.
Changlin WangSchool of Life Science and Technology, Harbin Institute of Technology, 150000, Harbin, China. wangcl@hit.edu.cn.
Yu LiSchool of Life Science and Technology, Harbin Institute of Technology, 150000, Harbin, China. liyugene@hit.edu.cn.
Harbin Institute of Technology · CNNanjing University of Chinese Medicine · CNThird Affiliated Hospital of Harbin Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The establishment of functional neuronal connectivity is dependent on the neuronal migration and the accurate positioning of neurons in the developing brain. Abnormal neuronal migration can trigger neuronal maturation defects and apoptosis. However, many genetic bases remain unclear in neuronal migration disorders during brain development. In this study, we reported that MARVELD1-defected mice displayed motor and cognitive dysfunction resulting from aberrant neuronal migration during brain development. The laminar organization of the cerebral cortex and cerebellum in MARVELD1 knockout (KO) mice is disrupted, indicating impaired radial neuronal migration. Furthermore, we used the cerebellum as a model to explore the radial neuronal migration processes, and the results demonstrated that the proper neuronal migration depended on MARVELD1 expression in glial cells of the developing brain. MARVELD1 suppressed the expression of ITGB1 and FAK Tyr397 phosphorylation in glia-dependent manner. The inhibition of the MARVELD1/ITGB1/FAK signalling pathway in MARVELD1 KO mice could reverse the defects in neuronal migration in vitro. Our findings revealed that MARVELD1 regulated neuronal migration by mediating the formation of glial fibres and ITGB1/FAK signalling pathway. The depletion of MARVELD1 during mouse brain development led to the abnormity of motor and cognition functions.

Indexed as

AnimalsCell MovementCerebellar CortexCognitive DysfunctionExercise TestFocal Adhesion Kinase 1Gene Knockout TechniquesIntegrin beta1Membrane ProteinsMiceMice, Inbred C57BLMice, KnockoutMicrotubule-Associated ProteinsMovementNeurogenesisNeurogliaFocal Adhesion Kinase 1Integrin beta1MARVELD1 protein, mouseMembrane ProteinsMicrotubule-Associated ProteinsPtk2 protein, mouse

Identifiers

PMID30250269
PMCPMC6155261
OpenAlexW2890997906

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.